Aspirin inhibits platelet aggregation by permanently blocking COX-1 enzymes, reducing thromboxane A2 synthesis. In dialysis patients, careful dosing is crucial to prevent excess bleeding.

Aspirin reduces platelet clotting function by irreversibly inhibiting COX-1, potentially increasing bleeding risks in dialysis patients. Monitoring and dosage adjustments are essential.

Dialysis patients taking aspirin for platelet aggregation must be monitored closely due to elevated bleeding risk, necessitating regular blood tests to ensure safe aspirin levels.